EOM Pharmaceutical Holdings Provides an Update on Its Lead Drug Candidate EOM613

PR NewswireNov 7, 2023 20:00

EOM Pharmaceutical Holdings Announces Topline Results of Its COVID-19 Clinical Trial of EOM613 in Brazil

PR NewswireSep 6, 2023 19:00

IPO Roundup: Richtech Robotics, Triller and More

Seeking AlphaAug 7, 2023 20:47

EOM Pharmaceuticals Shelves Plans to Uplist Shares, Raise $15M

Seeking AlphaAug 4, 2023 06:01

EOM PHARMACEUTICAL HOLDINGS, INC. ANNOUNCES NAME CHANGE FROM IMMUNOCELLULAR THERAPEUTICS, LTD.

PR NewswireNov 10, 2022 23:10

EOM Pharmaceuticals files to uplist to Nasdaq

Seeking AlphaJun 25, 2022 05:08